The State of Jharkhand has created a conducive eco-system for manufacturing industry, has identified Pharmaceutical sector as Thrust Sector in its Industrial Policy.
Cost-competitiveness, availability of infrastructure, natural resources, a sound policy and regulatory environment are the key factors for Jharkhand to attract investments in Pharma sector.
A dedicated Pharma park having an area of 35 acres has been proposed to be established in Bijupara, Ranchi. The project is approved by the Ministry of MSME to tap the grant under Micro Small Enterprises – Cluster Development Programme- (MSE-CDP) scheme. Out of the 35 acres about 23 acres of land has been demarcated into 54 plots.
Pharma Park, Bijupara
India has a prominent and rapidly growing presence in global pharmaceuticals. India is the largest provider of generic medicines, occupying a 20% share in global supply by volume and supplies 62% of global demand for vaccines. Pharmaceuticals export from India stood at US$ 16.3 billion in FY20. The total market size of the Indian Pharma Industry is expected to reach US$130 billion by 2030.
The state of Jharkhand has identified the Pharmaceutical sector as a Thrust Sector in its Industrial Policy. The market value of the Pharma Industry in the state has grown from Rs 896 Cr in FY15 to Rs 1248 Cr in FY17. The market has grown on an average of 18% during the last 3 years. The state is contributing 5% of the market in East India and 1% of the overall Indian Pharmaceutical Market. Jharkhand has the key resources: infrastructure, natural resources, cost-competitiveness, a sound policy and regulatory environment, required to create a conducive eco-system for the manufacturing industry and to attract investments in this sector.
Jharkhand Pharmaceutical industry is rapidly growing at a faster pace. The market value of the Industry in the state is around Rs 896 Cr in FY15 and it has grown to Rs 1248 Cr in FY17. The market has grown on average of 18% during last 3 years.
The state is contributing ~5% of East Indian Market and 1% of whole Indian Pharmaceutical Market. Anti infective, Gastrointestinals medicines occupies major market share i.e.,17% & 14% share and growing at 12%, & 17% respectively. Followed by Cardic medicines with 10%, Respiratory medicines with 9% of market share.